• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).

作者信息

Chao Elizabeth C, Astbury Caroline, Deignan Joshua L, Pronold Melissa, Reddi Honey V, Weitzel Jeffrey N

机构信息

Division of Genetic and Genomic Medicine, Department of Pediatrics, University of California, Irvine, CA, USA.

Ambry Genetics, Aliso Viejo, CA, USA.

出版信息

Genet Med. 2021 Jul;23(7):1179-1184. doi: 10.1038/s41436-021-01138-5. Epub 2021 Apr 16.

DOI:10.1038/s41436-021-01138-5
PMID:33864022
Abstract
摘要

相似文献

1
Incidental detection of acquired variants in germline genetic and genomic testing: a points to consider statement of the American College of Medical Genetics and Genomics (ACMG).生殖系基因和基因组检测中获得性变异的偶然发现：美国医学遗传学与基因组学学会（ACMG）的一份要点声明
Genet Med. 2021 Jul;23(7):1179-1184. doi: 10.1038/s41436-021-01138-5. Epub 2021 Apr 16.
2
Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG).肿瘤检测患者种系变异报告的注意事项：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2020 Jul;22(7):1142-1148. doi: 10.1038/s41436-020-0783-8. Epub 2020 Apr 23.
3
Points to consider in the detection of germline structural variants using next-generation sequencing: A statement of the American College of Medical Genetics and Genomics (ACMG).使用下一代测序检测种系结构变异时需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2023 Feb;25(2):100316. doi: 10.1016/j.gim.2022.09.017. Epub 2022 Dec 12.
4
Points to consider when assessing relationships (or suspecting misattributed relationships) during family-based clinical genomic testing: a statement of the American College of Medical Genetics and Genomics (ACMG).基于家庭的临床基因组检测中评估关系（或怀疑关系错误归因）时需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2020 Aug;22(8):1285-1287. doi: 10.1038/s41436-020-0821-6. Epub 2020 May 14.
5
Patient re-contact after revision of genomic test results: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).基因组检测结果修订后的患者重新联系：需考虑的要点——美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2019 Apr;21(4):769-771. doi: 10.1038/s41436-018-0391-z. Epub 2018 Dec 22.
6
Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG).避免不公平歧视和基因信息滥用需考虑的要点：美国医学遗传学与基因组学学会（ACMG）声明
Genet Med. 2022 Mar;24(3):512-520. doi: 10.1016/j.gim.2021.11.002. Epub 2021 Dec 16.
7
The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于将ACMG次要发现建议用于普通人群筛查的政策声明。
Genet Med. 2019 Jul;21(7):1467-1468. doi: 10.1038/s41436-019-0502-5. Epub 2019 Apr 25.
8
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).美国医学遗传学与基因组学学会（ACMG）关于临床外显子组和基因组测序中次要发现报告的ACMG SF v3.1清单：一项政策声明
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
9
DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG).基于DNA的筛查与群体健康：美国医学遗传学与基因组学学会（ACMG）为项目及赞助组织提供的一份需考虑要点声明
Genet Med. 2021 Jun;23(6):989-995. doi: 10.1038/s41436-020-01082-w. Epub 2021 Mar 16.
10
ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).ACMG SF v3.2 临床外显子组和基因组测序中报告次要发现的列表：美国医学遗传学与基因组学学会 (ACMG) 的政策声明。
Genet Med. 2023 Aug;25(8):100866. doi: 10.1016/j.gim.2023.100866. Epub 2023 Jun 22.

引用本文的文献

1
Dipping Into the Phenotypic Implications of Mosaic Variants.深入探究嵌合变异的表型影响
Neurol Genet. 2025 Apr 1;11(2):e200256. doi: 10.1212/NXG.0000000000200256. eCollection 2025 Apr.
2
Myelodysplastic syndrome diagnosed by genetic testing for hereditary cancer: a case report.通过遗传性癌症基因检测诊断的骨髓增生异常综合征：一例报告
NPJ Genom Med. 2025 May 15;10(1):39. doi: 10.1038/s41525-025-00476-6.
3
Low Allele Frequency Variants Identified on Germline Multi-Gene Panel Testing for Cancer Predisposition Can Suggest the Presence of Constitutional Mosaicism.
在癌症易感性的种系多基因检测中鉴定出的低频变异可能提示存在体细胞镶嵌现象。
Clin Cancer Res. 2025 Jul 1;31(13):2814-2823. doi: 10.1158/1078-0432.CCR-24-4105.
4
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the Breast.癌症易感基因中的致病变异易导致乳腺导管原位癌。
Clin Cancer Res. 2025 Jan 6;31(1):130-138. doi: 10.1158/1078-0432.CCR-24-1884.
5
Molecular pathophysiology of germline mutations in acute myeloid leukemia.胚系突变在急性髓系白血病中的分子病理生理学。
Int J Hematol. 2024 Oct;120(4):417-426. doi: 10.1007/s12185-024-03824-x. Epub 2024 Aug 16.
6
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism.应用国家综合癌症网络指南诊断和处理疑似致病性 TP53 嵌合体的实际挑战。
JCO Precis Oncol. 2024 Jul;8:e2400006. doi: 10.1200/PO.24.00006.
7
[Not Available].[无可用内容]
Med Genet. 2022 May 7;34(1):53-68. doi: 10.1515/medgen-2022-2112. eCollection 2022 Apr.
8
Association Between Aortic Valve Sclerosis and Clonal Hematopoiesis of Indeterminate Potential.主动脉瓣硬化与不确定潜能的克隆性造血之间的关联。
Ann Lab Med. 2024 May 1;44(3):279-288. doi: 10.3343/alm.2023.0268. Epub 2024 Jan 11.
9
Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.实体瘤恶性肿瘤患者中的不定潜能克隆性造血
Cancer Res. 2022 Nov 15;82(22):4107-4113. doi: 10.1158/0008-5472.CAN-22-0985.
10
Prevalence of pathogenic germline variants in the circulating tumor DNA testing.循环肿瘤 DNA 检测中致病性种系变异的流行率。
Int J Clin Oncol. 2022 Oct;27(10):1554-1561. doi: 10.1007/s10147-022-02220-x. Epub 2022 Jul 23.